Clinical Determinants of von Willebrand Factor Antigen, Activity, and Factor VIII Levels in Transfusion‐Dependent Beta‐Thalassemia
Haemophilia · 16.11.2026
DOI: 10.1111/hae.70460 ↗Kurz gefasst
Fachartikel in der Zeitschrift Haemophilia, online erschienen am 16.11.2026. Verfasst von Shayan Bordbar und 7 weiteren Autor:innen. Beteiligte Einrichtung: Medical School, Shiraz University of Medical Sciences, Shiraz, Iran. Die Arbeit nennt 27 Literaturangaben. Gefördert von: Shiraz University of Medical Sciences.
Abstract (Originalsprache)
Introduction
Von Willebrand factor (VWF) and factor VIII (FVIII) levels are influenced by multiple physiological and disease‐related factors. Patients with transfusion‐dependent beta thalassemia (TDT) present a complex clinical setting characterized by chronic anaemia, iron overload, inflammation, and endothelial dysfunction, yet data on the determinants of VWF and FVIII in this population remain limited.
Aim
To evaluate VWF antigen (VWF:Ag), VWF:GPIbM, and FVIII activity in patients with TDT and identify their clinical and laboratory determinants.
Methods
In this cross‐sectional study, 180 patients with TDT from an outpatient thalassemia clinic in Shiraz, Iran, were enrolled. Demographic data, ABO blood group, splenectomy status, pre‐transfusion haemoglobin, platelet count, and serum ferritin were recorded. VWF:Ag, VWF:GPIbM, and FVIII activity were measured using standard coagulation assays. Independent predictors were identified using multivariable linear regression.
Results
Median VWF:Ag, VWF:GPIbM, and FVIII activity were 121 IU/dL, 121 IU/dL, and 100 IU/dL, respectively. Non‐O blood groups were associated with higher VWF:Ag, VWF:GPIbM, and FVIII activity compared with blood group O ( p < 0.001). Body mass index independently predicted VWF:Ag, VWF:GPIbM, and FVIII activity. Splenectomy was associated with higher FVIII activity. Platelet count was inversely associated with VWF:GPIbM, whereas pre‐transfusion haemoglobin showed an inverse association with FVIII activity. Serum ferritin was not significantly associated with VWF or FVIII levels.
Conclusion
VWF and FVIII levels in TDT are influenced by haemoglobin, blood group, body mass index, splenectomy status, and platelet count. These modifiers may complicate the interpretation of haemostatic assays and should be considered when evaluating bleeding disorders in this population.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical School, Shiraz University of Medical Sciences, Shiraz, Iran.
- Hematology-Oncology Clinic, American Hospital Dubai, Dubai, UAE.
- Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
- Dastgheib Hospital, Shiraz University of Medical Sciences, Shiraz, Iran.
- Pathology Department, Shiraz University of Medical Sciences, Shiraz, Iran.
ORCID-Profile: Mohammadreza Bordbar
Förderung
- Shiraz University of Medical Sciences
Zitieren
APA
Bordbar, S., Karimi, M., Shahsavani, A., Bazrafshan, A., Mokhtari, M., Haghpanah, S., Zekavat, O. R., & Bordbar, M. (2026). Clinical Determinants of von Willebrand Factor Antigen, Activity, and Factor VIII Levels in Transfusion‐Dependent Beta‐Thalassemia. Haemophilia. https://doi.org/10.1111/hae.70460
Vancouver
Bordbar S, Karimi M, Shahsavani A, Bazrafshan A, Mokhtari M, Haghpanah S, et al. Clinical Determinants of von Willebrand Factor Antigen, Activity, and Factor VIII Levels in Transfusion‐Dependent Beta‐Thalassemia. Haemophilia. 2026. doi:10.1111/hae.70460
BibTeX
@article{Bordbar2026,
author = {Bordbar, Shayan and Karimi, Mehran and Shahsavani, Amin and Bazrafshan, Asghar and Mokhtari, Maral and Haghpanah, Sezaneh and Zekavat, Omid Reza and Bordbar, Mohammadreza},
title = {Clinical Determinants of von Willebrand Factor Antigen, Activity, and Factor VIII Levels in Transfusion‐Dependent Beta‐Thalassemia},
journal = {Haemophilia},
year = {2026},
doi = {10.1111/hae.70460}
}
EUVIMED